SCHEMBL27425410

SCHEMBL27425410

O=C1Nc2ccccc2-c2ccccc2-c2ccccc21

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LRRK2 Q5S007 4/20 0.74
ACVR1 Q04771 2/20 0.74
PDGFRA P16234 1/20 0.74
FER P16591 1/20 0.74
LTK P29376 1/20 0.74
CDK8 P49336 1/20 0.74
DYRK1B Q9Y463 1/20 0.74
MAOA P21397 1/20 0.67
MAOB P27338 1/20 0.67
GSK3B P49841 1/20 0.67
CASP3 P42574 1/20 0.56
CASP2 P42575 1/20 0.56
CASP7 P55210 1/20 0.56
CASP6 P55212 1/20 0.56
CASP8 Q14790 1/20 0.56
L3MBTL1 Q9Y468 1/20 0.55
CSNK1G1 Q9HCP0 1/20 0.53
CHEK1 O14757 1/20 0.53
MAPT P10636 5/20 0.52
SMN1; SMN2 Q16637 3/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2420711 0.90 LRRK2 (0.90) LRRK2ACVR1PDGFRAFERLTK
SCHEMBL366728 0.90
SCHEMBL1368292 0.85 LRRK2 (1.00) LRRK2ACVR1PDGFRAFERLTK
Hydrochloric Acid SCHEMBL6299954 0.83 LRRK2 (0.95) LRRK2ACVR1PDGFRAFERLTK
SCHEMBL11993852 0.82 LRRK2 (0.63) LRRK2ACVR1PDGFRAFERLTK
SCHEMBL28886187 0.81 LRRK2 (0.75) LRRK2ACVR1PDGFRAFERLTK
Phthalimide SCHEMBL11040503 0.81 GSK3B (1.00) LRRK2ACVR1PDGFRAFERLTK
SCHEMBL181764 0.81 LRRK2 (0.59) LRRK2ACVR1PDGFRAFERLTK
SCHEMBL17816635 0.81 LRRK2 (0.59) LRRK2ACVR1PDGFRAFERLTK
Phthalimide SCHEMBL64 0.81 GSK3B (1.00) LRRK2ACVR1PDGFRAFERLTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240224783-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2024-07-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240224783-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OCIAD2, OCIAD1, ICOSLG LRRK2 358/4885ACVR1 3949/4885PDGFRA 2587/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.